Literature DB >> 17126807

Osteoclast formation is strongly reduced both in vivo and in vitro in the absence of CD47/SIRPalpha-interaction.

Pernilla Lundberg1, Cecilia Koskinen, Paul A Baldock, Hanna Löthgren, Asa Stenberg, Ulf H Lerner, Per-Arne Oldenborg.   

Abstract

Physical interaction between the cell surface receptors CD47 and signal regulatory protein alpha (SIRPalpha) was reported to regulate cell migration, phagocytosis, cytokine production, and macrophage fusion. However, it is unclear if the CD47/SIRPalpha-interaction can also regulate macrophage colony-stimulating factor (M-CSF) and receptor activator of nuclear factor (NF)-kappaB ligand (RANKL)-stimulated formation of osteoclasts. Here, we show that functional blocking antibodies to either CD47 or SIRPalpha strongly reduced formation of multinucleated tartrate-resistant acid phosphatase (TRAP)+ osteoclasts in cultures of murine hematopoietic cells, stimulated in vitro by M-CSF and RANKL. In addition, the numbers of osteoclasts formed in M-CSF/RANKL-stimulated bone marrow macrophage cultures from CD47-/- mice were strongly reduced, and bones of CD47-/- mice exhibited significantly reduced osteoclast numbers, as compared with wild-type controls. We conclude that the CD47/SIRPalpha interaction is important for M-CSF/RANKL-stimulated osteoclast formation both in vivo and in vitro, and that absence of CD47 results in decreased numbers of osteoclasts in CD47-/- mice.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17126807     DOI: 10.1016/j.bbrc.2006.11.057

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  34 in total

1.  Cutting edge: microRNA regulation of macrophage fusion into multinucleated giant cells.

Authors:  James R Sissons; Jacques J Peschon; Frank Schmitz; Rosa Suen; Mark Gilchrist; Alan Aderem
Journal:  J Immunol       Date:  2012-06-01       Impact factor: 5.422

2.  An essential role for the association of CD47 to SHPS-1 in skeletal remodeling.

Authors:  Laura A Maile; Victoria E DeMambro; Christine Wai; Sutada Lotinun; Ariel W Aday; Byron E Capps; Wesley G Beamer; Clifford J Rosen; David R Clemmons
Journal:  J Bone Miner Res       Date:  2011-09       Impact factor: 6.741

Review 3.  CD47 update: a multifaceted actor in the tumour microenvironment of potential therapeutic interest.

Authors:  E Sick; A Jeanne; C Schneider; S Dedieu; K Takeda; L Martiny
Journal:  Br J Pharmacol       Date:  2012-12       Impact factor: 8.739

4.  Lack of CD47 impairs bone cell differentiation and results in an osteopenic phenotype in vivo due to impaired signal regulatory protein α (SIRPα) signaling.

Authors:  Cecilia Koskinen; Emelie Persson; Paul Baldock; Åsa Stenberg; Ingrid Boström; Takashi Matozaki; Per-Arne Oldenborg; Pernilla Lundberg
Journal:  J Biol Chem       Date:  2013-08-29       Impact factor: 5.157

Review 5.  Foreign body reaction to biomaterials.

Authors:  James M Anderson; Analiz Rodriguez; David T Chang
Journal:  Semin Immunol       Date:  2007-12-26       Impact factor: 11.130

6.  Regulated proteolysis of nonmuscle myosin IIA stimulates osteoclast fusion.

Authors:  Brooke K McMichael; Robert B Wysolmerski; Beth S Lee
Journal:  J Biol Chem       Date:  2009-03-05       Impact factor: 5.157

7.  Role of CD47 and Signal Regulatory Protein Alpha (SIRPα) in Regulating the Clearance of Viable or Aged Blood Cells.

Authors:  Oldenborg Per-Arne
Journal:  Transfus Med Hemother       Date:  2012-09-17       Impact factor: 3.747

8.  Osteosarcoma is characterised by reduced expression of markers of osteoclastogenesis and antigen presentation compared with normal bone.

Authors:  L Endo-Munoz; A Cumming; S Sommerville; I Dickinson; N A Saunders
Journal:  Br J Cancer       Date:  2010-06-15       Impact factor: 7.640

9.  Glucose regulation of integrin-associated protein cleavage controls the response of vascular smooth muscle cells to insulin-like growth factor-I.

Authors:  Laura A Maile; Byron E Capps; Emily C Miller; Lee B Allen; Umadevi Veluvolu; Ariel W Aday; David R Clemmons
Journal:  Mol Endocrinol       Date:  2008-02-21

10.  CD47 regulates bone mass and tumor metastasis to bone.

Authors:  Ozge Uluçkan; Stephanie N Becker; Hongju Deng; Wei Zou; Julie L Prior; David Piwnica-Worms; William A Frazier; Katherine N Weilbaecher
Journal:  Cancer Res       Date:  2009-03-10       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.